LOGIN  |  REGISTER

Recent Insider Transactions - Mineralys Therapeutics (NASDAQ: MLYS)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
04/14/2025
Buy
$1.08
6,348
$7K
123,052
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
04/14/2025
Sell
$13.69
2,966
$41K
120,086
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
04/14/2025
Sell
$14.83
8,400
$125K
111,686
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
04/14/2025
Sell
$1.08
6,348
$7K
107,926
NASDAQ MLYS Mineralys Therapeutics
Levy Adam Scott / officer: CFO and Secretary
04/11/2025
Sell
$12.06
10,757
$130K
215,340
NASDAQ MLYS Mineralys Therapeutics
Congleton Jon / director, officer: Chief Executive Officer
04/11/2025
Sell
$12.19
15,319
$187K
862,289
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
04/01/2025
Buy
$1.08
1,606
$2K
172,475
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
04/01/2025
Sell
$15.00
30,574
$459K
141,901
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
04/01/2025
Sell
$16.02
2,791
$45K
139,110
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
04/01/2025
Sell
$16.77
22,406
$376K
116,704
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
04/01/2025
Sell
$1.08
1,606
$2K
114,274
NASDAQ MLYS Mineralys Therapeutics
Samsara BioCapital GP, LLC / 10 percent owner
03/13/2025
Buy
$13.50
600,000
$8.100M
5.67M
NASDAQ MLYS Mineralys Therapeutics
AKKARAJU SRINIVAS / director
03/13/2025
Buy
$13.50
600,000
$8.100M
5.67M
NASDAQ MLYS Mineralys Therapeutics
RA CAPITAL MANAGEMENT, L.P. / director
03/13/2025
Buy
$13.50
1.30M
$17.500M
4.28M
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
03/12/2025
Buy
$1.08
6,349
$7K
170,869
NASDAQ MLYS Mineralys Therapeutics
Rodman David Malcom / officer: Chief Medical Officer
03/12/2025
Sell
$1.08
6,349
$7K
115,880